View Financial HealthRitesh International 配当と自社株買い配当金 基準チェック /06Ritesh International配当金を支払った記録がありません。主要情報n/a配当利回り-1.3%バイバック利回り総株主利回り-1.3%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹60.53, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.Reported Earnings • May 23Full year 2026 earnings released: EPS: ₹4.23 (vs ₹3.86 in FY 2025)Full year 2026 results: EPS: ₹4.23 (up from ₹3.86 in FY 2025). Revenue: ₹1.67b (up 30% from FY 2025). Net income: ₹36.8m (up 11% from FY 2025). Profit margin: 2.2% (down from 2.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.New Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹564.8m market cap, or US$5.86m). Minor Risk High level of debt (44% net debt to equity).Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹48.16, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.お知らせ • May 13Ritesh International Limited to Report Q4, 2026 Results on May 21, 2026Ritesh International Limited announced that they will report Q4, 2026 results on May 21, 2026New Risk • Mar 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹444.3m market cap, or US$4.75m). Minor Risks High level of debt (44% net debt to equity). Share price has been volatile over the past 3 months (7.7% average weekly change).Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹47.40, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹1.39 (vs ₹1.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.39 (up from ₹1.06 in 3Q 2025). Revenue: ₹444.7m (up 14% from 3Q 2025). Net income: ₹11.9m (up 31% from 3Q 2025). Profit margin: 2.7% (up from 2.3% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 24Ritesh International Limited to Report Q3, 2026 Results on Jan 30, 2026Ritesh International Limited announced that they will report Q3, 2026 results on Jan 30, 2026Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹72.89, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹1.24 (vs ₹0.28 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.24 (up from ₹0.28 in 2Q 2025). Revenue: ₹387.5m (up 50% from 2Q 2025). Net income: ₹10.6m (up 340% from 2Q 2025). Profit margin: 2.7% (up from 0.9% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹64.83, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 15% over the past three years.お知らせ • Nov 04Ritesh International Limited to Report Q2, 2026 Results on Nov 10, 2025Ritesh International Limited announced that they will report Q2, 2026 results on Nov 10, 2025お知らせ • Oct 03Ritesh International Limited announced that it expects to receive INR 37.9086 million in fundingRitesh International Limited announces a private placement with Ritesh Arora and Rijul Arora to issue 820,000 Equity Shares at a price of INR 46.23 per share for gross proceeds of INR 37,908,600 on October 1, 2025.Valuation Update With 7 Day Price Move • Sep 24Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹48.13, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years.Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹32.69, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 64% over the past three years.お知らせ • Aug 25Ritesh International Limited, Annual General Meeting, Sep 19, 2025Ritesh International Limited, Annual General Meeting, Sep 19, 2025, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur IndiaValuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹28.60, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 55% over the past three years.Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹0.44 (vs ₹0.17 in 1Q 2025)First quarter 2026 results: EPS: ₹0.44 (up from ₹0.17 in 1Q 2025). Revenue: ₹350.5m (up 33% from 1Q 2025). Net income: ₹3.76m (up 162% from 1Q 2025). Profit margin: 1.1% (up from 0.5% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.お知らせ • Aug 02Ritesh International Limited to Report Q1, 2026 Results on Aug 07, 2025Ritesh International Limited announced that they will report Q1, 2026 results on Aug 07, 2025Valuation Update With 7 Day Price Move • May 28Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹42.78, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 1.5% over the past three years.Reported Earnings • May 22Full year 2025 earnings released: EPS: ₹3.86 (vs ₹0.093 loss in FY 2024)Full year 2025 results: EPS: ₹3.86 (up from ₹0.093 loss in FY 2024). Revenue: ₹1.29b (up 54% from FY 2024). Net income: ₹33.0m (up ₹33.8m from FY 2024). Profit margin: 2.6% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • May 14Ritesh International Limited to Report Q4, 2025 Results on May 21, 2025Ritesh International Limited announced that they will report Q4, 2025 results on May 21, 2025New Risk • May 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹291.6m market cap, or US$3.46m). Minor Risk Share price has been volatile over the past 3 months (8.6% average weekly change).Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹34.95, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹1.06 (vs ₹0.07 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.06 (up from ₹0.07 in 3Q 2024). Revenue: ₹391.6m (up 124% from 3Q 2024). Net income: ₹9.08m (up ₹8.46m from 3Q 2024). Profit margin: 2.3% (up from 0.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.お知らせ • Feb 06Ritesh International Limited to Report Nine Months, 2025 Results on Feb 13, 2025Ritesh International Limited announced that they will report nine months, 2025 results on Feb 13, 2025Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹32.19, the stock trades at a trailing P/E ratio of 64.8x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.Reported Earnings • Nov 06Second quarter 2025 earnings released: EPS: ₹0.28 (vs ₹0.01 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.28 (up from ₹0.01 in 2Q 2024). Revenue: ₹259.1m (up 28% from 2Q 2024). Net income: ₹2.41m (up ₹2.33m from 2Q 2024). Profit margin: 0.9% (up from 0% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.お知らせ • Oct 26Ritesh International Limited to Report Q2, 2025 Results on Nov 05, 2024Ritesh International Limited announced that they will report Q2, 2025 results on Nov 05, 2024お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 21, 2024Ritesh International Limited, Annual General Meeting, Sep 21, 2024, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur IndiaReported Earnings • Aug 10First quarter 2025 earnings released: EPS: ₹0.17 (vs ₹0.15 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.17 (up from ₹0.15 loss in 1Q 2024). Revenue: ₹264.1m (up 24% from 1Q 2024). Net income: ₹1.43m (up ₹2.72m from 1Q 2024). Profit margin: 0.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.お知らせ • Aug 02Ritesh International Limited to Report Q1, 2025 Results on Aug 09, 2024Ritesh International Limited announced that they will report Q1, 2025 results on Aug 09, 2024お知らせ • May 25Ritesh International Limited to Report Q4, 2024 Results on May 30, 2024Ritesh International Limited announced that they will report Q4, 2024 results on May 30, 2024Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Independent Director Komal Bhalla was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: ₹0.07 (vs ₹0.098 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.07 (down from ₹0.098 in 3Q 2023). Revenue: ₹175.1m (down 29% from 3Q 2023). Net income: ₹620.0k (down 26% from 3Q 2023). Profit margin: 0.4% (up from 0.3% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.お知らせ • Feb 07Ritesh International Limited to Report Q3, 2024 Results on Feb 13, 2024Ritesh International Limited announced that they will report Q3, 2024 results on Feb 13, 2024Recent Insider Transactions • Nov 10Non-Executive Director recently sold ₹478k worth of stockOn the 9th of November, Ritesh Arora sold around 16k shares on-market at roughly ₹30.79 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹2.0m more than they bought in the last 12 months.Reported Earnings • Oct 29Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.59 in 2Q 2023)Second quarter 2024 results: EPS: ₹0.01 (down from ₹0.59 in 2Q 2023). Revenue: ₹203.1m (down 37% from 2Q 2023). Net income: ₹83.0k (down 98% from 2Q 2023). Profit margin: 0% (down from 1.6% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.お知らせ • Oct 19Ritesh International Limited to Report Q2, 2024 Results on Oct 26, 2023Ritesh International Limited announced that they will report Q2, 2024 results on Oct 26, 2023Buying Opportunity • Sep 07Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.5%. The fair value is estimated to be ₹47.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 26, 2023Ritesh International Limited, Annual General Meeting, Sep 26, 2023, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) Sangrur Punjab India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2023 including Audited Balance Sheet as at March 31, 2023, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider and approve, with or without modification, the appointment of Mr. Rijul Arora, who retires by rotation and being eligible, offers himself for reappointment; and to discuss other business matters.Reported Earnings • Aug 16First quarter 2024 earnings released: ₹0.15 loss per share (vs ₹1.99 profit in 1Q 2023)First quarter 2024 results: ₹0.15 loss per share (down from ₹1.99 profit in 1Q 2023). Revenue: ₹212.5m (down 57% from 1Q 2023). Net loss: ₹1.29m (down 108% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 08Ritesh International Limited to Report Q1, 2024 Results on Aug 14, 2023Ritesh International Limited announced that they will report Q1, 2024 results on Aug 14, 2023Recent Insider Transactions • Jun 02Additional Non-Executive Director recently sold ₹386k worth of stockOn the 1st of June, Ritesh Arora sold around 9k shares on-market at roughly ₹44.48 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹727k. Insiders have been net sellers, collectively disposing of ₹1.5m more than they bought in the last 12 months.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹44.36, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 1,265% over the past three years.Reported Earnings • May 27Full year 2023 earnings released: EPS: ₹1.23 (vs ₹4.17 in FY 2022)Full year 2023 results: EPS: ₹1.23 (down from ₹4.17 in FY 2022). Revenue: ₹1.27b (down 9.8% from FY 2022). Net income: ₹10.5m (down 71% from FY 2022). Profit margin: 0.8% (down from 2.5% in FY 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 153% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 19Ritesh International Limited to Report Q4, 2023 Results on May 25, 2023Ritesh International Limited announced that they will report Q4, 2023 results on May 25, 2023Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹55.39, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,285% over the past three years.Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹42.21, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 560% over the past three years.Recent Insider Transactions • Mar 08Additional Non-Executive Director recently sold ₹727k worth of stockOn the 6th of March, Ritesh Arora sold around 17k shares on-market at roughly ₹41.57 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹49.40, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 648% over the past three years.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹54.00, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 744% over the past three years.Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹0.098 (vs ₹0.73 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.098 (down from ₹0.73 in 3Q 2022). Revenue: ₹246.0m (down 32% from 3Q 2022). Net income: ₹840.0k (down 87% from 3Q 2022). Profit margin: 0.3% (down from 1.7% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 26Ritesh International Ltd to Report Q3, 2023 Results on Feb 02, 2023Ritesh International Ltd announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 02, 2023Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹76.45, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,811% over the past three years.Reported Earnings • Nov 06Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: ₹322.9m (down 7.4% from 2Q 2022). Net income: ₹5.06m (up 5.0% from 2Q 2022). Profit margin: 1.6% (up from 1.4% in 2Q 2022). The increase in margin was driven by lower expenses.お知らせ • Oct 29Ritesh International Ltd to Report Q2, 2023 Results on Nov 04, 2022Ritesh International Ltd announced that they will report Q2, 2023 results on Nov 04, 2022Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹87.75, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,387% over the past three years.Valuation Update With 7 Day Price Move • Sep 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,496% over the past three years.Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.75, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,126% over the past three years.お知らせ • Aug 13Ritesh International Ltd, Annual General Meeting, Sep 16, 2022Ritesh International Ltd, Annual General Meeting, Sep 16, 2022, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) District Sangrur, Punjab -148021 Ahmednagar India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2022 including Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider the appointment of Mr. Rajiv Arora, who retires by rotation and being eligible, offers himself for reappointment; to ratify the remuneration payable to the Cost Auditor (Verma Khushwinder & Co.) for the FY 2022-23; and to consider other matters.お知らせ • Aug 06Ritesh International Ltd to Report Q1, 2023 Results on Aug 12, 2022Ritesh International Ltd announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 12, 2022Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹53.75, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,180% over the past three years.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹50.80, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 719% over the past three years.Valuation Update With 7 Day Price Move • May 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹36.10, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 688% over the past three years.Buying Opportunity • May 11Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 7.2%. The fair value is estimated to be ₹40.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% over the last 3 years. Meanwhile, the company has become profitable.お知らせ • May 10Ritesh International Ltd to Report Q4, 2022 Results on May 18, 2022Ritesh International Ltd announced that they will report Q4, 2022 results on May 18, 2022Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Mar 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹31.85, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 314% over the past three years.Buying Opportunity • Feb 23Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹37.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% per annum over the last 3 years. The company has become profitable over the last 3 years.Board Change • Feb 17Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹38.15, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 570% over the past three years.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹0.56 (vs ₹0.45 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2022 results: Revenue: ₹348.5m (up 93% from 2Q 2021). Net income: ₹4.82m (up 26% from 2Q 2021). Profit margin: 1.4% (down from 2.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.Board Change • Sep 03Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Additional Non-Executive Independent Director Kajal Rai was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Jul 01Full year 2021 earnings released: EPS ₹2.38 (vs ₹0.36 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹748.8m (up 72% from FY 2020). Net income: ₹20.3m (up ₹17.2m from FY 2020). Profit margin: 2.7% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 18Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹46.05, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 208% over the past three years.Valuation Update With 7 Day Price Move • May 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹43.05, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹37.05, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years.Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹28.65, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.Is New 90 Day High Low • Feb 15New 90-day high: ₹14.68The company is up 13% from its price of ₹13.00 on 17 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.Reported Earnings • Feb 12Third quarter 2021 earnings released: EPS ₹2.48 (vs ₹1.07 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹247.6m (up 102% from 3Q 2020). Net income: ₹21.2m (up 132% from 3Q 2020). Profit margin: 8.6% (up from 7.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 03Ritesh International Ltd to Report Q3, 2021 Results on Feb 10, 2021Ritesh International Ltd announced that they will report Q3, 2021 results on Feb 10, 2021お知らせ • Dec 13Ritesh International Ltd Announces Appointment of Ritesh Arora as an Additional DirectorRitesh International Ltd. announced that Mr. Ritesh Arora has been appointed by the board as an Additional Director of the company with effect from December 12, 2020.Valuation Update With 7 Day Price Move • Oct 22Market pulls back on stock over the past weekAfter last week's 16% share price decline to ₹11.40, the stock is trading at a trailing P/E ratio of 12.6x, down from the previous P/E ratio of 14.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 171%.Valuation Update With 7 Day Price Move • Oct 17Market pulls back on stock over the past weekAfter last week's 17% share price decline to ₹12.86, the stock is trading at a trailing P/E ratio of 14.2x, down from the previous P/E ratio of 17.1x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 199%.お知らせ • Oct 13Ritesh International Ltd Announces Retirement of Reeta Challana as an Independent DirectorRitesh International Ltd. announced that at the Annual General Meeting held on September 28, 2020, the shareholders rejected the the resolution of re-appointment of Mrs. Reeta Challana as an independent Director.お知らせ • Oct 02Ritesh International Ltd Appoints Kajal Rai as Additional Director (Independent Director)Ritesh International Ltd. announced that Ms. Kajal Rai has been appointed by the board as an Additional Director (Independent Director of the company with effect from October 1, 2020.Is New 90 Day High Low • Sep 30New 90-day high: ₹13.20The company is up 269% from its price of ₹3.58 on 01 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.お知らせ • Aug 09Ritesh International Ltd to Report Q1, 2021 Results on Aug 14, 2020Ritesh International Ltd announced that they will report Q1, 2021 results on Aug 14, 2020お知らせ • Jun 20Ritesh International Ltd to Report Q4, 2020 Results on Jun 26, 2020Ritesh International Ltd announced that they will report Q4, 2020 results on Jun 26, 2020決済の安定と成長配当データの取得安定した配当: 519097の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 519097の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Ritesh International 配当利回り対市場519097 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (519097)n/a市場下位25% (IN)0.3%市場トップ25% (IN)1.5%業界平均 (Chemicals)0.8%アナリスト予想 (519097) (最長3年)n/a注目すべき配当: 519097は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 519097は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 519097の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 519097が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/17 19:31終値2026/07/17 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ritesh International Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹60.53, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.
Reported Earnings • May 23Full year 2026 earnings released: EPS: ₹4.23 (vs ₹3.86 in FY 2025)Full year 2026 results: EPS: ₹4.23 (up from ₹3.86 in FY 2025). Revenue: ₹1.67b (up 30% from FY 2025). Net income: ₹36.8m (up 11% from FY 2025). Profit margin: 2.2% (down from 2.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
New Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹564.8m market cap, or US$5.86m). Minor Risk High level of debt (44% net debt to equity).
Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹48.16, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.
お知らせ • May 13Ritesh International Limited to Report Q4, 2026 Results on May 21, 2026Ritesh International Limited announced that they will report Q4, 2026 results on May 21, 2026
New Risk • Mar 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹444.3m market cap, or US$4.75m). Minor Risks High level of debt (44% net debt to equity). Share price has been volatile over the past 3 months (7.7% average weekly change).
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹47.40, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.
Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹1.39 (vs ₹1.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.39 (up from ₹1.06 in 3Q 2025). Revenue: ₹444.7m (up 14% from 3Q 2025). Net income: ₹11.9m (up 31% from 3Q 2025). Profit margin: 2.7% (up from 2.3% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 24Ritesh International Limited to Report Q3, 2026 Results on Jan 30, 2026Ritesh International Limited announced that they will report Q3, 2026 results on Jan 30, 2026
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹72.89, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.
Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹1.24 (vs ₹0.28 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.24 (up from ₹0.28 in 2Q 2025). Revenue: ₹387.5m (up 50% from 2Q 2025). Net income: ₹10.6m (up 340% from 2Q 2025). Profit margin: 2.7% (up from 0.9% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹64.83, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 15% over the past three years.
お知らせ • Nov 04Ritesh International Limited to Report Q2, 2026 Results on Nov 10, 2025Ritesh International Limited announced that they will report Q2, 2026 results on Nov 10, 2025
お知らせ • Oct 03Ritesh International Limited announced that it expects to receive INR 37.9086 million in fundingRitesh International Limited announces a private placement with Ritesh Arora and Rijul Arora to issue 820,000 Equity Shares at a price of INR 46.23 per share for gross proceeds of INR 37,908,600 on October 1, 2025.
Valuation Update With 7 Day Price Move • Sep 24Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹48.13, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years.
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹32.69, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 64% over the past three years.
お知らせ • Aug 25Ritesh International Limited, Annual General Meeting, Sep 19, 2025Ritesh International Limited, Annual General Meeting, Sep 19, 2025, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur India
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹28.60, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 55% over the past three years.
Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹0.44 (vs ₹0.17 in 1Q 2025)First quarter 2026 results: EPS: ₹0.44 (up from ₹0.17 in 1Q 2025). Revenue: ₹350.5m (up 33% from 1Q 2025). Net income: ₹3.76m (up 162% from 1Q 2025). Profit margin: 1.1% (up from 0.5% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
お知らせ • Aug 02Ritesh International Limited to Report Q1, 2026 Results on Aug 07, 2025Ritesh International Limited announced that they will report Q1, 2026 results on Aug 07, 2025
Valuation Update With 7 Day Price Move • May 28Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹42.78, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 1.5% over the past three years.
Reported Earnings • May 22Full year 2025 earnings released: EPS: ₹3.86 (vs ₹0.093 loss in FY 2024)Full year 2025 results: EPS: ₹3.86 (up from ₹0.093 loss in FY 2024). Revenue: ₹1.29b (up 54% from FY 2024). Net income: ₹33.0m (up ₹33.8m from FY 2024). Profit margin: 2.6% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • May 14Ritesh International Limited to Report Q4, 2025 Results on May 21, 2025Ritesh International Limited announced that they will report Q4, 2025 results on May 21, 2025
New Risk • May 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹291.6m market cap, or US$3.46m). Minor Risk Share price has been volatile over the past 3 months (8.6% average weekly change).
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹34.95, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.
Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹1.06 (vs ₹0.07 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.06 (up from ₹0.07 in 3Q 2024). Revenue: ₹391.6m (up 124% from 3Q 2024). Net income: ₹9.08m (up ₹8.46m from 3Q 2024). Profit margin: 2.3% (up from 0.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 06Ritesh International Limited to Report Nine Months, 2025 Results on Feb 13, 2025Ritesh International Limited announced that they will report nine months, 2025 results on Feb 13, 2025
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹32.19, the stock trades at a trailing P/E ratio of 64.8x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.
Reported Earnings • Nov 06Second quarter 2025 earnings released: EPS: ₹0.28 (vs ₹0.01 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.28 (up from ₹0.01 in 2Q 2024). Revenue: ₹259.1m (up 28% from 2Q 2024). Net income: ₹2.41m (up ₹2.33m from 2Q 2024). Profit margin: 0.9% (up from 0% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
お知らせ • Oct 26Ritesh International Limited to Report Q2, 2025 Results on Nov 05, 2024Ritesh International Limited announced that they will report Q2, 2025 results on Nov 05, 2024
お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 21, 2024Ritesh International Limited, Annual General Meeting, Sep 21, 2024, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur India
Reported Earnings • Aug 10First quarter 2025 earnings released: EPS: ₹0.17 (vs ₹0.15 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.17 (up from ₹0.15 loss in 1Q 2024). Revenue: ₹264.1m (up 24% from 1Q 2024). Net income: ₹1.43m (up ₹2.72m from 1Q 2024). Profit margin: 0.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 02Ritesh International Limited to Report Q1, 2025 Results on Aug 09, 2024Ritesh International Limited announced that they will report Q1, 2025 results on Aug 09, 2024
お知らせ • May 25Ritesh International Limited to Report Q4, 2024 Results on May 30, 2024Ritesh International Limited announced that they will report Q4, 2024 results on May 30, 2024
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Independent Director Komal Bhalla was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: ₹0.07 (vs ₹0.098 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.07 (down from ₹0.098 in 3Q 2023). Revenue: ₹175.1m (down 29% from 3Q 2023). Net income: ₹620.0k (down 26% from 3Q 2023). Profit margin: 0.4% (up from 0.3% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.
お知らせ • Feb 07Ritesh International Limited to Report Q3, 2024 Results on Feb 13, 2024Ritesh International Limited announced that they will report Q3, 2024 results on Feb 13, 2024
Recent Insider Transactions • Nov 10Non-Executive Director recently sold ₹478k worth of stockOn the 9th of November, Ritesh Arora sold around 16k shares on-market at roughly ₹30.79 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹2.0m more than they bought in the last 12 months.
Reported Earnings • Oct 29Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.59 in 2Q 2023)Second quarter 2024 results: EPS: ₹0.01 (down from ₹0.59 in 2Q 2023). Revenue: ₹203.1m (down 37% from 2Q 2023). Net income: ₹83.0k (down 98% from 2Q 2023). Profit margin: 0% (down from 1.6% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.
お知らせ • Oct 19Ritesh International Limited to Report Q2, 2024 Results on Oct 26, 2023Ritesh International Limited announced that they will report Q2, 2024 results on Oct 26, 2023
Buying Opportunity • Sep 07Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.5%. The fair value is estimated to be ₹47.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 26, 2023Ritesh International Limited, Annual General Meeting, Sep 26, 2023, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) Sangrur Punjab India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2023 including Audited Balance Sheet as at March 31, 2023, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider and approve, with or without modification, the appointment of Mr. Rijul Arora, who retires by rotation and being eligible, offers himself for reappointment; and to discuss other business matters.
Reported Earnings • Aug 16First quarter 2024 earnings released: ₹0.15 loss per share (vs ₹1.99 profit in 1Q 2023)First quarter 2024 results: ₹0.15 loss per share (down from ₹1.99 profit in 1Q 2023). Revenue: ₹212.5m (down 57% from 1Q 2023). Net loss: ₹1.29m (down 108% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 08Ritesh International Limited to Report Q1, 2024 Results on Aug 14, 2023Ritesh International Limited announced that they will report Q1, 2024 results on Aug 14, 2023
Recent Insider Transactions • Jun 02Additional Non-Executive Director recently sold ₹386k worth of stockOn the 1st of June, Ritesh Arora sold around 9k shares on-market at roughly ₹44.48 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹727k. Insiders have been net sellers, collectively disposing of ₹1.5m more than they bought in the last 12 months.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹44.36, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 1,265% over the past three years.
Reported Earnings • May 27Full year 2023 earnings released: EPS: ₹1.23 (vs ₹4.17 in FY 2022)Full year 2023 results: EPS: ₹1.23 (down from ₹4.17 in FY 2022). Revenue: ₹1.27b (down 9.8% from FY 2022). Net income: ₹10.5m (down 71% from FY 2022). Profit margin: 0.8% (down from 2.5% in FY 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 153% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 19Ritesh International Limited to Report Q4, 2023 Results on May 25, 2023Ritesh International Limited announced that they will report Q4, 2023 results on May 25, 2023
Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹55.39, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,285% over the past three years.
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹42.21, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 560% over the past three years.
Recent Insider Transactions • Mar 08Additional Non-Executive Director recently sold ₹727k worth of stockOn the 6th of March, Ritesh Arora sold around 17k shares on-market at roughly ₹41.57 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹49.40, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 648% over the past three years.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹54.00, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 744% over the past three years.
Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹0.098 (vs ₹0.73 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.098 (down from ₹0.73 in 3Q 2022). Revenue: ₹246.0m (down 32% from 3Q 2022). Net income: ₹840.0k (down 87% from 3Q 2022). Profit margin: 0.3% (down from 1.7% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 26Ritesh International Ltd to Report Q3, 2023 Results on Feb 02, 2023Ritesh International Ltd announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 02, 2023
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹76.45, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,811% over the past three years.
Reported Earnings • Nov 06Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: ₹322.9m (down 7.4% from 2Q 2022). Net income: ₹5.06m (up 5.0% from 2Q 2022). Profit margin: 1.6% (up from 1.4% in 2Q 2022). The increase in margin was driven by lower expenses.
お知らせ • Oct 29Ritesh International Ltd to Report Q2, 2023 Results on Nov 04, 2022Ritesh International Ltd announced that they will report Q2, 2023 results on Nov 04, 2022
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹87.75, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,387% over the past three years.
Valuation Update With 7 Day Price Move • Sep 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,496% over the past three years.
Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.75, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,126% over the past three years.
お知らせ • Aug 13Ritesh International Ltd, Annual General Meeting, Sep 16, 2022Ritesh International Ltd, Annual General Meeting, Sep 16, 2022, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) District Sangrur, Punjab -148021 Ahmednagar India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2022 including Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider the appointment of Mr. Rajiv Arora, who retires by rotation and being eligible, offers himself for reappointment; to ratify the remuneration payable to the Cost Auditor (Verma Khushwinder & Co.) for the FY 2022-23; and to consider other matters.
お知らせ • Aug 06Ritesh International Ltd to Report Q1, 2023 Results on Aug 12, 2022Ritesh International Ltd announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 12, 2022
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹53.75, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,180% over the past three years.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹50.80, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 719% over the past three years.
Valuation Update With 7 Day Price Move • May 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹36.10, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 688% over the past three years.
Buying Opportunity • May 11Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 7.2%. The fair value is estimated to be ₹40.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% over the last 3 years. Meanwhile, the company has become profitable.
お知らせ • May 10Ritesh International Ltd to Report Q4, 2022 Results on May 18, 2022Ritesh International Ltd announced that they will report Q4, 2022 results on May 18, 2022
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Mar 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹31.85, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 314% over the past three years.
Buying Opportunity • Feb 23Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹37.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% per annum over the last 3 years. The company has become profitable over the last 3 years.
Board Change • Feb 17Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹38.15, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 570% over the past three years.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹0.56 (vs ₹0.45 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2022 results: Revenue: ₹348.5m (up 93% from 2Q 2021). Net income: ₹4.82m (up 26% from 2Q 2021). Profit margin: 1.4% (down from 2.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.
Board Change • Sep 03Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Additional Non-Executive Independent Director Kajal Rai was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jul 01Full year 2021 earnings released: EPS ₹2.38 (vs ₹0.36 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹748.8m (up 72% from FY 2020). Net income: ₹20.3m (up ₹17.2m from FY 2020). Profit margin: 2.7% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹46.05, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 208% over the past three years.
Valuation Update With 7 Day Price Move • May 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹43.05, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹37.05, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years.
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹28.65, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.
Is New 90 Day High Low • Feb 15New 90-day high: ₹14.68The company is up 13% from its price of ₹13.00 on 17 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.
Reported Earnings • Feb 12Third quarter 2021 earnings released: EPS ₹2.48 (vs ₹1.07 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹247.6m (up 102% from 3Q 2020). Net income: ₹21.2m (up 132% from 3Q 2020). Profit margin: 8.6% (up from 7.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 03Ritesh International Ltd to Report Q3, 2021 Results on Feb 10, 2021Ritesh International Ltd announced that they will report Q3, 2021 results on Feb 10, 2021
お知らせ • Dec 13Ritesh International Ltd Announces Appointment of Ritesh Arora as an Additional DirectorRitesh International Ltd. announced that Mr. Ritesh Arora has been appointed by the board as an Additional Director of the company with effect from December 12, 2020.
Valuation Update With 7 Day Price Move • Oct 22Market pulls back on stock over the past weekAfter last week's 16% share price decline to ₹11.40, the stock is trading at a trailing P/E ratio of 12.6x, down from the previous P/E ratio of 14.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 171%.
Valuation Update With 7 Day Price Move • Oct 17Market pulls back on stock over the past weekAfter last week's 17% share price decline to ₹12.86, the stock is trading at a trailing P/E ratio of 14.2x, down from the previous P/E ratio of 17.1x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 199%.
お知らせ • Oct 13Ritesh International Ltd Announces Retirement of Reeta Challana as an Independent DirectorRitesh International Ltd. announced that at the Annual General Meeting held on September 28, 2020, the shareholders rejected the the resolution of re-appointment of Mrs. Reeta Challana as an independent Director.
お知らせ • Oct 02Ritesh International Ltd Appoints Kajal Rai as Additional Director (Independent Director)Ritesh International Ltd. announced that Ms. Kajal Rai has been appointed by the board as an Additional Director (Independent Director of the company with effect from October 1, 2020.
Is New 90 Day High Low • Sep 30New 90-day high: ₹13.20The company is up 269% from its price of ₹3.58 on 01 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.
お知らせ • Aug 09Ritesh International Ltd to Report Q1, 2021 Results on Aug 14, 2020Ritesh International Ltd announced that they will report Q1, 2021 results on Aug 14, 2020
お知らせ • Jun 20Ritesh International Ltd to Report Q4, 2020 Results on Jun 26, 2020Ritesh International Ltd announced that they will report Q4, 2020 results on Jun 26, 2020